Pfm Health Sciences, LP Crispr Therapeutics Ag Transaction History
Pfm Health Sciences, LP
- $1.71 Billion
- Q3 2024
A detailed history of Pfm Health Sciences, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pfm Health Sciences, LP holds 41,000 shares of CRSP stock, worth $2.08 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
41,000Holding current value
$2.08 Million% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRSP
# of Institutions
493Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$403 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$381 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$152 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$151 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$151 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....